Dial Schedule M: India’s drug manufacturing practices to undergo major overhaul

Dial Schedule M: India’s drug manufacturing practices to undergo major overhaul

Dial Schedule M: India’s drug manufacturing practices to undergo major overhaul

by Lexplosion | Feb 28, 2024 | Compliance, Legal analysis, Pharmaceuticals

If you are a pharmaceutical company in India with a turnover of more than Rs. 250 crores, you only... Read More

Payment Banks and Ways to Steer Clear from RBI’s Wrath – The Regulatory Regime

Payment Banks and Ways to Steer Clear from RBI’s Wrath – The Regulatory Regime

by Lexplosion | Feb 13, 2024 | Compliance, Legal analysis, NBFC

Reams have already been written on the RBI’s recent decision to impose stringent strictures on... Read More

NBFCs to implement technology-driven compliance solution by June 30th 2024: RBI

NBFCs to implement technology-driven compliance solution by June 30th 2024: RBI

by Lexplosion | Feb 6, 2024 | Compliance, Legal analysis

If you are a upper or middle layer[1] Non-Banking Financial Company (“NBFC”) or a part of other... Read More

Navigating the Compliance Maze: Implementing the right Compliance Management Solution

Navigating the Compliance Maze: Implementing the right Compliance Management Solution

by Lexplosion | Dec 5, 2023 | Compliance, Legal analysis

The legal technology landscape has evolved significantly over the past 15 years, with numerous... Read More

Transformative Trends: Artificial Intelligence in Regulatory Compliance

Transformative Trends: Artificial Intelligence in Regulatory Compliance

by Lexplosion | Nov 15, 2023 | Compliance, Legal analysis

Introduction Compliance management is the process of ensuring that an organization complies with... Read More

« Older Entries